Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®

NCT00319553 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

647

Enrollment

INDUSTRY

Sponsor class

Conditions

Pertussis
Tetanus
Diphtheria

Interventions

BIOLOGICAL: ADACEL®:Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed
BIOLOGICAL: BOOSTRIX®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed

Sponsor

Sanofi